The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma

被引:146
作者
Rahman, Maryam [1 ]
Abbatematteo, Joseph [1 ]
De Leo, Edward K. [1 ]
Kubilis, Paul S. [1 ]
Vaziri, Sasha [1 ]
Bova, Frank [1 ]
Sayour, Elias [1 ]
Mitchell, Duane [1 ]
Quinones-Hinojosa, Alfredo [2 ]
机构
[1] Univ Florida, Dept Neurosurg, Box 100265, Gainesville, FL 32610 USA
[2] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA
关键词
neurological deficit; postoperative morbidity; glioblastoma; resection; extent of resection; quality of life; oncology; GROSS TOTAL RESECTION; FLUORESCENCE-GUIDED RESECTION; 5-AMINOLEVULINIC ACID; MALIGNANT GLIOMA; AWAKE CRANIOTOMY; SURGICAL RESECTION; RADIATION-THERAPY; RESIDUAL TUMOR; EXTENT; SURGERY;
D O I
10.3171/2016.7.JNS16396
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE An increased extent of resection (EOR) has been shown to improve overall survival of patients with glioblastoma (GBM) but has the potential for causing a new postoperative neurological deficit. To investigate the impact of surgical neurological morbidity on survival, the authors performed a retrospective analysis of the clinical data from patients with GBM to quantify the impact of a new neurological deficit on the survival benefit achieved with an increased EOR. METHODS The data from all GBM patients who underwent resection at the University of Florida from 2010 to 2015 with postoperative imaging within 72 hours of surgery were included in the study. Retrospective analysis was performed on clinical outcomes and tumor volumes determined on postoperative and follow-up imaging examinations. RESULTS Overall, 115 patients met the inclusion criteria for the study. Tumor volume at the time of presentation was a median of 59 cm(3) (enhanced on T1-weighted MRI scans). The mean EOR (+/- SD) was 94.2% +/- 8.7% (range 59.9%-100%). Almost 30% of patients had a new postoperative neurological deficit, including motor weakness, sensory deficits, language difficulty, visual deficits, confusion, and ataxia. The neurological deficits had resolved in 41% of these patients on subsequent follow-up examinations. The median overall survival was 13.1 months (95% CI 10.9-15.2 months). Using a multipredictor Cox model, the authors observed that increased EOR was associated with improved survival except for patients with smaller tumor volumes (<= 15 cm(3)). A residual volume of 2.5 cm(3) or less predicted a favorable overall survival. Developing a postoperative neurological deficit significantly affected survival (9.2 months compared with 14.7 months, p = 0.02), even if the neurological deficit had resolved by the first follow-up. However, there was a trend of improved survival among patients with resolution of a neurological deficit by the first follow-up compared with patients with a permanent neurological deficit. Any survival benefit from achieving a 95% FOR was abrogated by the development of a new neurological deficit postoperatively. CONCLUSIONS Developing a new neurological deficit after resection of GBM is associated with a decrease in overall survival. A careful balance between FOR and neurological compromise needs to be taken into account to reduce the likelihood of neurological morbidity from surgery.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 39 条
  • [21] SURGICAL RESECTION AND RADIATION-THERAPY VERSUS BIOPSY AND RADIATION-THERAPY IN THE TREATMENT OF GLIOBLASTOMA-MULTIFORME
    KRETH, FW
    WARNKE, PC
    SCHEREMET, R
    OSTERTAG, CB
    [J]. JOURNAL OF NEUROSURGERY, 1993, 78 (05) : 762 - 766
  • [22] A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
    Lacroix, M
    Abi-Said, D
    Fourney, DR
    Gokaslan, ZL
    Shi, WM
    DeMonte, F
    Lang, FF
    McCutcheon, IE
    Hassenbusch, SJ
    Holland, E
    Hess, K
    Michael, C
    Miller, D
    Sawaya, R
    [J]. JOURNAL OF NEUROSURGERY, 2001, 95 (02) : 190 - 198
  • [23] A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas
    Lau, Darryl
    Hervey-Jumper, Shawn L.
    Chang, Susan
    Molinaro, Annette M.
    McDermott, Michael W.
    Phillips, Joanna J.
    Berger, Mitchel S.
    [J]. JOURNAL OF NEUROSURGERY, 2016, 124 (05) : 1300 - 1309
  • [24] Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
    Laws, ER
    Parney, IF
    Huang, W
    Anderson, F
    Morris, AM
    Asher, A
    Lillehei, KO
    Bernstein, M
    Brem, H
    Sloan, A
    Berger, MS
    Chang, S
    [J]. JOURNAL OF NEUROSURGERY, 2003, 99 (03) : 467 - 473
  • [25] The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li, Yan Michael
    Suki, Dima
    Hess, Kenneth
    Sawaya, Raymond
    [J]. JOURNAL OF NEUROSURGERY, 2016, 124 (04) : 977 - 988
  • [26] ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME
    McGirt, Matthew J.
    Mukherjee, Debraj
    Chaichana, Kaisorn L.
    Than, Khoi D.
    Weingart, Jon D.
    Quinones-Hinojosa, Alfredo
    [J]. NEUROSURGERY, 2009, 65 (03) : 463 - 470
  • [27] FIVE-AMINOLEVULINIC ACID FOR FLUORESCENCE-GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS: A PHASE II STUDY
    Nabavi, Arya
    Thurm, Holger
    Zountsas, Basilios
    Pietsch, Thorsten
    Lanfermann, Heinrich
    Pichlmeier, Uwe
    Mehdorn, Maximilian
    [J]. NEUROSURGERY, 2009, 65 (06) : 1070 - 1076
  • [28] Intraoperative Magnetic Resonance Imaging in Intracranial Glioma Resection: A Single-Center, Retrospective Blinded Volumetric Study
    Olubiyi, Olutayo Ibukunolu
    Ozdemir, Aysegul
    Incekara, Fatih
    Tie, Yanmei
    Dolati, Parviz
    Hsu, Liangge
    Santagata, Sandro
    Chen, Zhenrui
    Rigolo, Laura
    Golby, Alexandra J.
    [J]. WORLD NEUROSURGERY, 2015, 84 (02) : 528 - 536
  • [29] THE RELATIONSHIP BETWEEN SURVIVAL AND THE EXTENT OF THE RESECTION IN PATIENTS WITH SUPRATENTORIAL MALIGNANT GLIOMAS
    QUIGLEY, MR
    MAROON, JC
    [J]. NEUROSURGERY, 1991, 29 (03) : 385 - 389
  • [30] Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: High-field iMRI versus conventional and 5-ALA-assisted surgery
    Roder, C.
    Bisdas, S.
    Ebner, F. H.
    Honegger, J.
    Naegele, T.
    Ernemann, U.
    Tatagiba, M.
    [J]. EJSO, 2014, 40 (03): : 297 - 304